Baycrest

BrainMatters - Fall 2022

Baycrest Health Sciences & Baycrest Foundation Publications

Issue link: http://baycrest.uberflip.com/i/1479362

Contents of this Issue

Navigation

Page 17 of 31

16 • BrainMatters • Fall/Winter 2022 RRI scientists are now concerned that the lingering effects of COVID -19 can ultimately increase the risk of Alzheimer's disease and other forms of dementia. SUPPORTING OLDER ADULTS DURING THE COVID-19 PANDEMIC & BEYOND We know that COVID-19 can affect our respiratory systems but it may also affect our brains. Research from Baycrest's Rotman Research Institute (RRI) and elsewhere shows that the COVID-19 virus can enter through one's nose and attack the brain, resulting in long-term neurological symptoms, such as trouble thinking and memory loss. RRI scientists are now concerned that the lingering effects of COVID-19 can ultimately increase the risk of Alzheimer's disease and other forms of dementia. Patients who have had COVID-19 are experiencing brain-related symptoms, ranging from headaches to anxiety, depression, hallucinations and changes in smell and taste. BRAIN STRUCTURE AND FUNCTION A team of scientists at the RRI, led by Dr. Allison Sekuler, President and Chief Scientist at the Baycrest Academy for Research and Education, and Sandra A. Rotman Chair in Cognitive Neuroscience at the RRI, has collaborated with colleagues at Sunnybrook Health Sciences to examine the effects of COVID-19 on brain structure and function. In a small study, they conducted sensory, cognitive, and clinical assessments, along with electroencephalography (EEG) testing and magnetic resonance imaging (MRI) of the brain in 41 recovered COVID-19 patients and people who experienced COVID-like symptoms but tested negative.

Articles in this issue

view archives of Baycrest - BrainMatters - Fall 2022